Accountability Healthcare Pharmaceuticals Telemedicine 
HIT Consultant
AUGUST 5, 2022
What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. in Q2 2022, with only Acadia Healthcare posting a gain in share price.
HIT Consultant
JULY 26, 2022
Digital transformation has increased healthcare access, but quality and consistency are lagging behind. The healthcare industry has gone digital faster than anyone could’ve expected. Digital health options like telemedicine and online pharmacies existed before the pandemic. Telemedicine and online pharma have their merits.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
SEPTEMBER 26, 2022
There was tremendous interest in telemedicine before 2020. For instance, digital-first healthcare aggregators had been testing programs for telemedicine but, since 2020, the demand for telehealth services has exploded across the globe. The new normal has thrown up opportunities as well as risks for pharmaceutical companies.
HIT Consultant
DECEMBER 18, 2023
Natalie Tkachenko, Healthcare Software Solutions Consultant at NIX To obtain test results today, there’s no need to visit the hospital. This became possible thanks to electronic health records, telemedicine, and cloud solutions. However, along with advancements, challenges in digital healthcare are increasing.
Bill Of Health
MAY 30, 2023
By Katie Gu Mifepristone’s shifting legal terrain may soon raise new privacy considerations regarding telemedicine data collection, security, and disclosure. The Mifepristone Debates Mifepristone is the first medication of a two-part drug regime that accounts for approximately half of legal abortions in the United States.
HIT Consultant
AUGUST 21, 2023
Shameem Hameed, CEO of blueBriX Now more than ever, the healthcare sector is under pressure to curb rising costs, increase accessibility, alleviate issues caused by worker shortages, and improve both clinician and patient outcomes. Increasingly, there is a challenge of transparency in reimbursement models within healthcare.
Health Populi
AUGUST 7, 2018
employers are growing activist roles as stakeholders in the healthcare system, according to the 2019 Large Employers Health Care Strategy and Plan Design Survey from the National Business Group on Health (NBGH). One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain.
Expert insights. Personalized for you.
98 
Let's personalize your content